Mucocutaneous Lymph Node Syndrome: Clinical Trials

5 trials for Mucocutaneous Lymph Node Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 withdrawn. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 2, Recruiting 2, Withdrawn 1

Follow Mucocutaneous Lymph Node Syndrome: new trials by email Literature Review of Mucocutaneous Lymph Node Syndrome trials Research Report on Mucocutaneous Lymph Node Syndrome

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Non Inferiority KawasakI Trial With Anakinra
Anakinra, Intravenous Immunoglobulins, Human - Kawasaki Disease, Anakinra
Phase 4WithdrawnMeyer Children's Hospital IRCCS2026-04-012026-10-26
Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease
Rivaroxaban Oral Tablet [Xarelto], Aspirin or Clopidogrel, Warfarin - Kawasaki Disease, Coronary Artery Aneurysm
Phase 4RecruitingChildren's Hospital of Fudan University1002025-06-012026-07-06
Model-informed Dose Optimization for Rivaroxaban in Children With Giant Coronary Artery Aneurysm After Kawasaki Disease
Rivaroxaban (Xarelto) - Kawasaki Disease, Pilot Study
Phase 4RecruitingChildren's Hospital of Fudan University102024-01-102026-10-22
Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease
Immunoglobulin G, Acetylsalicylic acid - Kawasaki Disease
Phase 4CompletedGreen Cross Corporation452019-02-012020-05-21
Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease
immunoglobulin G - Kawasaki Disease
Phase 4CompletedGreen Cross Corporation452012-01-012012-09-20

Narrower conditions

Coronary Aneurysm (2)

Broader conditions

Cardiovascular Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Lymphatic Diseases (5)  ·  Skin Diseases (5)  ·  Skin Diseases, Vascular (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Vascular Diseases (5)  ·  Vasculitis (5)  ·  Aneurysm (2)  ·  Coronary Disease (2)  ·  Heart Diseases (2)  ·  Myocardial Ischemia (2)

Interventions

Aspirin (2)  ·  Immunoglobulin G (2)  ·  Rivaroxaban (2)  ·  Clopidogrel (1)  ·  Immunoglobulins, Intravenous (1)  ·  Interleukin 1 Receptor Antagonist Protein (1)  ·  Warfarin (1)  ·  acarboxyprothrombin (1)

Sponsors

Children's Hospital of Fudan University (2)  ·  Green Cross Corporation (2)  ·  Meyer Children's Hospital IRCCS (1)

Countries

China (2)  ·  South Korea (2)

Top investigators

Fang Liu, MD (2)  ·  Gabriele Simonini, Prof (1)  ·  June Huh, MD,Ph.D (1)  ·  Mi Young Han, MD, Ph.D. (1)